874 — Guangzhou Baiyunshan Pharmaceutical Holdings Co Cashflow Statement
0.000.00%
HealthcareBalancedMicro Cap
Annual cashflow statement for Guangzhou Baiyunshan Pharmaceutical Holdings Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | CAS | CAS | CAS | CAS | CAS |
Status: | Final | Final | Final | Final | Final |
Changes in Working Capital | -6,828 | -7,319 | -7,096 | -8,244 | -7,806 |
Other Operating Cash Flow | |||||
Cash from Operating Activities | 585 | 5,673 | 6,999 | 4,104 | 3,442 |
Capital Expenditures | -877 | -1,255 | -1,384 | -1,628 | -1,128 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -212 | 323 | -5,869 | -1,486 | -4,836 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -1,088 | -932 | -7,253 | -3,115 | -5,964 |
Financing Cash Flow Items | -29.9 | -397 | -8.9 | -619 | -319 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 1,439 | -1,494 | 45.9 | -1,978 | -1,006 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 932 | 3,248 | -209 | -981 | -3,521 |